Natural State Laboratories Chooses SOPHiA GENETICS to Help Launch their In-House Hereditary Cancer Testing

    • SOPHiA GENETICS technology will help increase cancer research abilities

      BOSTON and LAUSANNE, Switzerland, May 16, 2023 – SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space and a leader in data-driven medicine, today announced that Natural State Laboratories, a private, full-service, state-of-the-art molecular laboratory based in Little Rock, Arkansas, has chosen SOPHiA GENETICS technology to help them expand their cancer testing and research capabilities. Natural State Laboratories will soon begin using SOPHiA DDM™ to launch in-house testing for hereditary cancers.